Menu Back toCMIC Holdings Innovation Theater: Make the Impossible Possible - An Innovative Partnership for Market Entry in Japan
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
DIA 2021 Global Annual Meeting
CMIC Holdings Innovation Theater: Make the Impossible Possible - An Innovative Partnership for Market Entry in Japan
CMIC HOLDINGS Co., Ltd.
- CMIC Co., Ltd., Japan
CMIC, the leading CRO in Japan, and MEDIPAL, the leading pharma wholesaler joined forces to create OrphanPacific with a mission: accelerate the introduction of innovative medicines to treat rare diseases in Japan. Inspired by the experience of outsourcing, OrphanPacific introduced IPM, Innovative Pharma Model, assisting biotech firms without local operations to introduce their asset in Japan. The partnership with BioCryst provides an exceptional business case demonstrating the value of IPM.
- OrphanPacific, Inc., President, Representative Director
- CMIC HOLDINGS Co., Ltd./Orphan Pacific Inc, Japan
Megan Sniecinski, MBA
- Chief Business Officer
- BioCryst Pharmaceuticals, Inc., United States